Bacterial Infections clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • VABOMERE in Pediatric Subjects With Bacterial Infections

    Sorry, in progress, not accepting new patients

    A single dose infusion of Vabomere (meropenem-vaborbactam) is being tested for dose-finding, pharmacokinetics, safety, and tolerability in pediatric subjects from birth to less than 18 years of age with serious bacterial infections

    at UCLA